2008-as idegen nyelvű publikációk

  • Kerekes G, Szekanecz Z, Dér H, Sándor Z, Lakos G, Muszbek L, Csipö I, Sipka S, Seres I, Paragh G, Kappelmayer J, Szomják E, Veres K, Szegedi G, Shoenfeld Y, Soltész P. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 35, 398-406, 2008.
  • Kiss F, Buslig J, Szegedi I, Scholtz B, Kappelmayer J, Kiss, C. Early relapse after rituximab chemoimmunotherapy. Pediatr Blood Cancer 50, 372-375, 2008.
  • Kiss F, Simon A, Csáthy L, Hevessy Z, Katona E, Kiss C, Kappelmayer J. A coagulation factor becomes useful in the study of acute leukemias: studies with blood coagulation factor XIII. Cytometry 73, 3, 194-201, 2008.
  • Miner JJ, Xia L, Yago T, Kappelmayer J, Liu Z, Klopocki AG, Shao B, McDaniel JM, Setiadi H, Schmidtke DW, McEver RP. Separable requirements for cytoplasmic domain of PSGL-1 in leukocyte rolling and signaling under flow. Blood 112, 2035-2045, 2008.
  • Mohás M, Szigeti N, Markó L, Molnár GA, Cseh J, Laczy B, Tamaskó M, Balla J, Kappelmayer J, Wagner L, Wagner, Csiky B, Nagy J, Wittmann I. Serum total LDH activity and LDH-2 isozyme in nephrotic syndrome. Kidney Blood Press Res 31, 47-54, 2008.
  • Jiao H, Tóth B, Erdős M, Fransson I, Rákóczi E, Balogh I, Magyarics Z, Dérfalvi B, Csorba G, Szaflarska A, Megarbane A, Akatcherian C, Dbaibo G, Rajnavölgyi E, Hammarström L, Kere J, Lefranc G, Maródi L. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups. Mol Immunol 46(1):202-6, 2008.
  • Szekanecz E, Szűcs G, Szekanecz Z, Tarr T, Antal-Szalmás P, Szamosi S, Szántó J, Kiss E. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: Associations with organ manifestations, immunolaboratory markers and disease activity indices. J Autoimmun 31(4):372-6. 2008.
  • Zold E, Szodoray P, Gaal J, Kappelmayer J, Csathy L, Gyimesi E, Zeher M, Szegedi Gy, Bodolay E. Vitamin D deficiency in Undifferentiated Connective Tissue Disease: a marker of progression into defined systemic autoimmune diseases. Arthritis Res Ther 10, R123, 2008.
  • Boda Z., Udvardy M., Rázsó K., Farkas K., Tóth J., Jámbor L., Oláh Z., Ilonczai P., Szarvas M., Kappelmayer J., Veréb Z., Rajnavölgyi E.: Stem Cell Therapy: A Promising and Prospective Approach in the Treatment of Patients With Severe Buerger’s Disease. Clin Appl Thromb Hemost 15(5):552-60, 2008.
  • A V Oláh, J. Mátyus, J. Kappelmayer, L. Újhelyi, J. Varga: Effect of creatinine methods on the eGFR: the new and old formulae. Hungarian Medical Journal Vol 2/1 (2008) 49-53.

Frissítés dátuma: 2019.06.27.